Logo Logo
Switch Language to German

Batra, A.; Petersen, K. U.; Hoch, E.; Mann, K.; Kröger, C.; Schweizer, C.; Jähne, A.; Rüther, T.; Thürauf, N. and Mühlig, S. (2016): Psycho- und Pharmakotherapie bei schädlichem Tabakgebrauch und -abhängigkeit. In: Nervenarzt, Vol. 87, No. 1: pp. 35-45

Full text not available from 'Open Access LMU'.


Tobacco consumption is one of the major preventable health risk factors. In Germany approximately 110,000 people prematurely die from tobacco-related diseases and approximately 50 % of regular smokers are considered to be tobacco dependent. Nevertheless, motivation to quit smoking is low and the long-term abstinence rates after attempts to stop smoking without professional support are far below 10 %. As part of the S3 treatment guidelines 78 recommendations for motivation and early interventions for smokers unwilling to quit as well as psychotherapeutic and pharmacological support for smokers willing to quit were formulated after an systematic search of the current literature. More than 50 professional associations adopted the recommendations and background information in a complex certification process. In this article the scientific evidence base regarding the psychotherapeutic and pharmacological treatment options as well as recommendations and further information about indications and treatment implementation are presented. By following these guidelines for treatment of heavy smokers who are willing to quit combined with individual and group therapies on the basis of behavioral treatment strategies and pharmacological support, long-term success rates of almost 30 % can be achieved.

Actions (login required)

View Item View Item